DelveInsight's Castration-sensitive Prostate Cancer Market Insights report includes a comprehensive understanding of current treatment practices, CSPC emerging drugs, market share of individual ...

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Authors retain all rights in any data supplements associated ...

Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial In total, 172 patients ...

Data released earlier this month showed that across nearly 600 cancer patient groups, Roche was rated as having the best reputation among pharmas in 2023. Now, PatientView has offered an even deeper ...

Spherix Global Insights surveyed 103 gastroenterologists on their thoughts on the ulcerative colitis prescription market. 1. The providers projected significant growth for Takeda’s Entyvio, Janssen’s ...

A mandatory, nonmedical switch from infliximab to a biosimilar for inflammatory bowel disease (IBD) indicated that the two treatments have similar clinical outcomes. After 1 year, there were no ...

MINNEAPOLIS/ST. PAUL (12/11/2024) — Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found that a DNA sequencing test for advanced ...

IBD is rising worldwide and is now a global disease. With the expanding armamentarium of medical therapies, including biologics and small molecules, there is a decline in hospitalisation rates and IBD ...